SiriusPoint Ltd. (SPNT)
NYSE: SPNT · Real-Time Price · USD
19.26
+0.10 (0.52%)
Jun 5, 2025, 4:00 PM - Market closed
SiriusPoint Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for SiriusPoint stock has a target of 17, which predicts a -11.73% decrease from the current stock price of 19.26.
Price Target: $17.00 (-11.73%)
Analyst Consensus: Hold
* Price targets were last updated on Apr 15, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for SiriusPoint is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | May '25 | Jun '25 |
---|---|---|
Strong Buy | 0 | 0 |
Buy | 0 | 0 |
Hold | 1 | 1 |
Sell | 0 | 0 |
Strong Sell | 0 | 0 |
Total | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Jefferies | Jefferies | Hold Initiates $17 | Hold | Initiates | $17 | -11.73% | Apr 15, 2025 |
Financial Forecast
Revenue This Year
2.67B
from 2.66B
Increased by 0.32%
Revenue Next Year
2.83B
from 2.67B
Increased by 6.00%
EPS This Year
2.22
from 1.04
Increased by 113.51%
EPS Next Year
2.50
from 2.22
Increased by 12.61%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 2.7B | 2.9B | 3.0B |
Avg | 2.7B | 2.8B | 3.0B |
Low | 2.6B | 2.7B | 2.8B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 3.3% | 9.1% | 7.8% |
Avg | 0.3% | 6.0% | 4.7% |
Low | -3.6% | 1.8% | 0.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 2.47 | 2.79 | 2.99 |
Avg | 2.22 | 2.50 | 2.91 |
Low | 1.96 | 2.21 | 2.79 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 137.7% | 25.4% | 19.7% |
Avg | 113.5% | 12.6% | 16.3% |
Low | 88.5% | -0.7% | 11.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.